Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]

Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]

Gupta AK, Pokhriyal R, Das U, et al. Neuropsychiatr Dis Treat. 2019;15:2073–2085. The authors wish to advise of typographical errors in Figures 1 and 2 and Table 3, the correct unit of apolipoprotein E concentration is μg/ml, and not pg/ml. Page 2077, Figure 1A, y axis, the text &am...

Full description

Bibliographic Details
Main Authors: Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
cerebro-spinal fluid
parkinson’s disease
schizophrenia
dopamine
apolipoprotein e
α-synuclein
biomarkers
treatment monitoring
Online Access:https://www.dovepress.com/corrigendum-evaluation-of-alpha-synuclein-and-apolipoprotein-e-as-pote-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/corrigendum-evaluation-of-alpha-synuclein-and-apolipoprotein-e-as-pote-peer-reviewed-fulltext-article-NDT

Similar Items